This Article Full Text (PDF) All Versions of this Article: 0003319709332959v1 60/3/362    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Smout, J. Articles by Stansby, G. Search for Related Content PubMed PubMed Citation Articles by Smout, J. Articles by Stansby, G. Social Bookmarking                         What's this?

Platelet Function Following Acute Cerebral Ischemia

Northern Vascular Centre Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom

Alexander Dyker

Acute Stroke Services Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom

Marcus Cleanthis

Northern Vascular Centre Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom

Gary Ford

Acute Stroke Services Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom

Patrick Kesteven

Department of Haematology, Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom

Gererd Stansby

Northern Vascular Centre Freeman Hospital, Northern Vascular Centre, Newcastle Upon Tyne, United Kingdom, Gerard.Stansby{at}nuth.northy.nhs.uk

Background: Studies have previously identified increased levels of platelet activation following acute ischemic stroke. In order to evaluate new antiplatelet agents and their combinations, there is a need for accurate measures of platelet activation. Methods: Blood was taken from 17 patients within 24 hours of an acute ischemic stroke, and then at 3, 7, 14 and 42 days. For comparison, a group of 18 stable arteriopaths had identical tests performed. Platelet aggregation was measured using a free platelet counting technique, and platelet surface P-selectin and monocyte platelet aggregates (MPAs) were measured using flow cytometry. Soluble P-selectin and D-dimers were measured by an enzyme linked immune assay. Results: The initial level of MPAs was significantly raised in the stroke patients compared with the stable patients (p = 0.04, 14.2% vs. 9.3%); however, this difference was not significantly higher than later study points (14.2%, 10.1%, 9.3%, 11.9%, 11.3%; days 1, 3, 7, 14 and 42 respectively. Day 1 vs. day 7 p = 0.07 ANOVA). No changes in P-selectin or platelet aggregation were identified. D-dimer levels were significantly higher on day 7 than day 42 (p < 0.01), and fibrinogen levels were elevated on both days 3 and 14 compared with day 42. Fibrinogen levels were not elevated compared with stable patients. Conclusions: MPA levels are elevated following an acute ischemic stroke compared to stable patients, but no significant change was seen with other platelet markers. This study suggests MPAs are a more sensitive marker of platelet activation than either P-selectin or aggregation.

Key Words: stroke • platelet • flow cytometry • monocyte

This version was published on June 1, 2009

Angiology, Vol. 60, No. 3, 362-369 (2009)
DOI: 10.1177/0003319709332959


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?